Does obesity cause hair loss? While obesity is not a single, direct cause, growing evidence suggests that excess body weight can disrupt the hair growth cycle through chronic inflammation, hormonal imbalances, and nutritional deficiencies. Hair follicles are sensitive to changes in the body's internal environment, and several mechanisms linked to obesity — including elevated androgens, insulin resistance, and oxidative stress — may increase the risk or severity of hair thinning in susceptible individuals. Understanding these connections is key to identifying treatable causes and accessing appropriate support.

How Obesity Can Contribute to Hair Loss

Obesity contributes to hair loss indirectly through chronic low-grade inflammation, oxidative stress, and metabolic changes that can push hair follicles prematurely into the shedding phase, though the relationship is associative rather than directly causal.

Not sure if this is normal? Chat with one of our pharmacists →

Obesity is not a single, direct cause of hair loss, but there is a growing body of observational evidence suggesting that excess body weight can create physiological conditions that disrupt the normal hair growth cycle. The relationship is associative rather than definitively causal: obesity may increase the risk or severity of hair loss in susceptible individuals, rather than inevitably causing it. Hair follicles are sensitive structures that respond to changes in the body's internal environment, including inflammation, hormonal shifts, and nutritional imbalances — all of which are more prevalent in people living with obesity.

One key mechanism involves chronic low-grade inflammation, which is commonly associated with obesity. Adipose (fat) tissue, particularly visceral fat stored around the abdomen, is metabolically active and releases pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These inflammatory signals may interfere with the hair follicle cycle, potentially pushing follicles prematurely into the telogen (resting/shedding) phase — a condition known as telogen effluvium. However, the evidence linking obesity-related inflammation directly to telogen effluvium in humans remains largely associative.

Oxidative stress — an imbalance between free radicals and antioxidants in the body — is elevated in obesity and has been studied in relation to hair follicle health. Some research suggests oxidative damage may impair follicle function, though clinical evidence in humans is mixed and this area continues to evolve. The cumulative effect of inflammation, oxidative stress, and associated metabolic changes means that obesity may meaningfully contribute to hair thinning in susceptible individuals, but it is rarely the sole explanation.

Further reading: NHS Hair loss; Primary Care Dermatology Society (PCDS) hair loss guidance.

The Role of Hormones and Nutrition in Hair Thinning

Insulin resistance in obesity raises androgen levels and reduces SHBG, increasing free DHT that drives pattern hair loss; nutritional deficiencies in iron, vitamin D, zinc, and B12 can also impair follicle health and should be confirmed before supplementation.

Hormonal imbalances are a significant bridge between obesity and hair loss. Excess body fat — particularly around the abdomen — is associated with insulin resistance, which elevates circulating insulin levels. Hyperinsulinaemia can stimulate the ovaries or adrenal glands to produce more androgens (male hormones such as testosterone and dihydrotestosterone, or DHT). Importantly, insulin resistance also reduces sex hormone-binding globulin (SHBG), which increases the proportion of free testosterone and DHT available to act on hair follicles. Elevated DHT is a well-established driver of androgenetic alopecia (pattern hair loss) in both men and women. In women, this hormonal disruption can also manifest as part of polycystic ovary syndrome (PCOS), discussed further below.

Oestrogen and leptin — a hormone produced by fat cells — also play roles in hair follicle regulation. In obesity, leptin resistance can develop, and disrupted leptin signalling has been linked to impaired hair follicle cycling in some early studies, though this area of research remains experimental and no firm clinical conclusions can yet be drawn.

Nutritional deficiencies are another important consideration. People living with obesity may paradoxically experience micronutrient deficiencies due to poor dietary quality. Key nutrients for hair health include:

• Iron — deficiency is one of the most common causes of diffuse hair loss, particularly in women; diagnosis should be confirmed by serum ferritin before supplementation (see NICE CKS: Anaemia – iron deficiency)

• Zinc — essential for follicle repair and protein synthesis; supplementation without confirmed deficiency is not recommended, as excess zinc can impair copper absorption

• Vitamin D — low levels have been associated with alopecia areata and telogen effluvium in some studies, though causality is not established; supplementation should follow confirmed deficiency (see SACN/NHS Vitamin D guidance)

• Vitamin B12 — supports red blood cell formation; deficiency should be confirmed before supplementation

It is important to note that biotin (vitamin B7) deficiency is rare in the general population, and routine biotin supplementation is not recommended. The MHRA has issued a Drug Safety Update warning that high-dose biotin supplements can interfere with a range of laboratory tests (including thyroid function, troponin, and hormone assays), potentially causing falsely abnormal results. Patients taking biotin supplements should inform their GP or healthcare team before blood tests are taken.

The general principle is to test for and treat confirmed deficiencies rather than to supplement routinely. People who have undergone bariatric (weight-loss) surgery are at particular risk of nutritional deficiencies — including iron, vitamin B12, vitamin D, and zinc — and should receive ongoing monitoring and supplementation as guided by their surgical team.

A diet high in ultra-processed foods and low in vegetables, lean proteins, and whole grains — common in some dietary patterns associated with obesity — can deprive hair follicles of the building blocks they need to sustain healthy growth.

Further reading: NICE CKS: Polycystic ovary syndrome; NICE CKS: Anaemia – iron deficiency; MHRA Drug Safety Update: Biotin (vitamin B7) – interference with laboratory tests; NHS Vitamin D.

Medical Conditions Linked to Both Obesity and Hair Loss

PCOS, hypothyroidism, and type 2 diabetes are independently associated with both obesity and hair loss; identifying and treating these underlying conditions is the clinical priority, as hair health often improves with effective management.

Several medical conditions are independently associated with both obesity and hair loss, meaning that in some individuals, hair thinning may be a symptom of an underlying condition rather than a direct result of body weight alone. Identifying these conditions is clinically important, as treating the root cause can often improve hair health.

Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of reproductive age and is strongly associated with obesity. PCOS causes elevated androgen levels, which can lead to scalp hair thinning (androgenetic alopecia) alongside other symptoms such as irregular periods, acne, and excess facial or body hair. NICE CKS guidance on PCOS recommends lifestyle modification as a first-line intervention, with pharmacological options considered where appropriate.

Hypothyroidism (an underactive thyroid) is associated with obesity; people with obesity tend to have higher thyroid-stimulating hormone (TSH) levels on average, and symptoms of hypothyroidism — including diffuse hair loss, dry skin, fatigue, and weight gain — should prompt testing. Where overt hypothyroidism is confirmed, treatment with levothyroxine — available on the NHS — typically leads to gradual improvement in hair density over several months. See NICE CKS: Hypothyroidism for guidance on investigation and management.

Type 2 diabetes, which is closely linked to obesity, is associated with metabolic and microvascular changes that may affect peripheral tissues; whilst scalp-specific evidence is limited, these systemic changes may contribute to impaired follicle health in some individuals. Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome are also associated with hormonal and inflammatory changes that may contribute to hair loss. In all these cases, managing the underlying condition is the priority, and hair loss should be viewed as a potential clinical indicator warranting further investigation.

Further reading: NICE CKS: Polycystic ovary syndrome; NICE CKS: Hypothyroidism; NHS Type 2 diabetes overview.

When to Seek Advice from a GP or Specialist

Consult a GP if you experience sudden or patchy hair loss, hair loss with fatigue or hormonal symptoms, or scalp changes such as redness or scarring — the latter requires prompt dermatology referral to prevent permanent follicle damage.

Hair loss can be distressing, and whilst some degree of daily shedding (up to approximately 100 hairs per day) is entirely normal, certain patterns or associated symptoms warrant medical attention. It is advisable to consult a GP if you notice:

• Sudden or rapid hair shedding, particularly in clumps or across the whole scalp

• Patchy hair loss (which may suggest alopecia areata, an autoimmune condition, or — particularly if associated with scaling — a fungal infection such as tinea capitis, which requires mycological assessment)

• Hair loss accompanied by fatigue, weight changes, irregular periods, or skin changes — which may point to a hormonal or thyroid disorder

• Scalp changes such as redness, scaling, or scarring — suspected scarring alopecia (for example, lichen planopilaris or discoid lupus erythematosus) requires prompt referral to a consultant dermatologist, as early treatment is important to limit permanent follicle damage

• Hair loss that is causing significant psychological distress or affecting quality of life

Your GP will typically begin with a thorough history and examination, and will then request investigations guided by clinical suspicion — not every test is needed for every patient. Commonly considered tests include:

• Full blood count (to check for anaemia)

• Ferritin (iron stores)

• Thyroid function (TSH, free T4)

• Hormonal profile (including testosterone, SHBG, free androgen index, LH, FSH, and prolactin in women where PCOS or other hormonal causes are suspected)

• Vitamin D and B12 levels

• HbA1c (where metabolic risk or type 2 diabetes is a concern)

If an underlying cause is identified, appropriate treatment will be initiated or a referral made — for example, to an endocrinologist for hormonal conditions, or a consultant dermatologist for complex, scarring, or treatment-resistant alopecia. NHS dermatology services can provide specialist assessment, and in some cases referral to a trichologist (hair and scalp specialist) may be appropriate, though this is more commonly accessed privately.

Further reading: NICE CKS: Alopecia areata; Primary Care Dermatology Society (PCDS) hair loss guidance; British Association of Dermatologists (BAD) patient information leaflets.

Treatment and Management Options Available on the NHS

NHS treatment for hair loss depends on the confirmed underlying cause; options include iron or vitamin supplementation for deficiencies, minoxidil or finasteride for androgenetic alopecia, corticosteroids or baricitinib for alopecia areata, and weight management support to address hormonal drivers.

Treatment for hair loss on the NHS depends on the underlying cause identified during investigation. There is no universal NHS-funded treatment for cosmetic hair loss, but where a medical cause is established, management is typically covered.

For telogen effluvium caused by nutritional deficiencies, correcting the confirmed deficiency — through dietary advice or supplementation — is the primary approach. Iron supplementation is commonly prescribed for iron-deficiency-related hair loss where ferritin is low. Vitamin D or B12 may be recommended where levels are confirmed to be deficient. Results are gradual, often taking three to six months before visible improvement is noted.

For androgenetic alopecia, the topical treatment minoxidil (available over the counter in the UK) is widely used and can be effective in both men and women. Its precise mechanism is not fully understood, but it is thought to prolong the anagen (growth) phase of the hair cycle and may have effects on follicular vasodilation. It must be used continuously to maintain effect, and results typically take several months to become apparent. For men with androgenetic alopecia, finasteride 1 mg is licensed in the UK for this indication; it works by inhibiting the conversion of testosterone to DHT. Finasteride is not licensed for use in women and must not be used during pregnancy. Patients should discuss the benefits, risks, and need for ongoing use with their prescriber, with reference to the BNF and the medicine's Summary of Product Characteristics (SmPC).

In women with PCOS-related hair loss, spironolactone may be considered off-label as an anti-androgen. It is important to note that spironolactone is not licensed for hair loss in the UK; its use requires careful shared decision-making, effective contraception (as it is teratogenic), and monitoring of potassium levels and renal function. The combined oral contraceptive pill — particularly formulations with anti-androgenic progestogens — may help regulate hormone levels in some women, though its role is limited and venous thromboembolism (VTE) risk must be considered. Prescribing decisions should be guided by the BNF and individual SmPCs.

For alopecia areata, NHS treatment options include topical, intralesional, or oral corticosteroids, depending on the extent of hair loss. Baricitinib (a JAK inhibitor) has been approved by the MHRA and recommended by NICE for severe alopecia areata in adults meeting specific eligibility criteria; patients should be referred to a specialist dermatologist for assessment, as JAK inhibitors require specialist initiation and ongoing safety monitoring. Please refer to the current NICE technology appraisal guidance and the baricitinib SmPC (available via the eMC) for up-to-date eligibility criteria and safety information.

Weight management support — including referral to NHS weight management services or, where eligible, pharmacological treatment such as semaglutide under NICE TA875 guidance — may also indirectly benefit hair health by addressing the hormonal and inflammatory drivers of hair loss. Eligibility criteria apply; see NICE TA875 for details. It is worth noting that rapid weight loss itself can trigger telogen effluvium (see the Lifestyle section below), so gradual, supported weight management is preferable.

Patients should report any suspected side effects of medicines to the MHRA via the Yellow Card scheme (available at yellowcard.mhra.gov.uk).

Experiencing these side effects? Our pharmacists can help you navigate them →

Further reading: BNF: Minoxidil; Finasteride; Spironolactone; eMC/SmPC for individual medicines; NICE TA875: Semaglutide for managing overweight and obesity; NICE guidance on baricitinib for severe alopecia areata; NICE CKS: Alopecia areata.

Lifestyle Changes That May Support Hair and Overall Health

A balanced diet rich in lean protein, iron, and antioxidants, combined with at least 150 minutes of moderate physical activity per week, supports both follicle health and weight management; crash diets should be avoided as rapid weight loss is a recognised trigger for telogen effluvium.

Whilst medical treatment addresses specific causes, sustainable lifestyle changes can play a meaningful supporting role in both managing weight and improving the conditions that contribute to hair loss. These changes are not a substitute for medical care but can complement it effectively.

Diet is a cornerstone of both weight management and hair health. The NHS Eatwell Guide provides a practical framework for balanced eating. A diet rich in:

• Lean proteins (chicken, fish, legumes, eggs) — hair is primarily composed of the protein keratin, making adequate protein intake essential

• Iron-rich foods (red meat, spinach, lentils, fortified cereals) — particularly important for women

• Omega-3 fatty acids (oily fish, walnuts, flaxseed) — which may support scalp health; direct evidence for hair growth benefit in humans is limited, but these foods contribute to an anti-inflammatory dietary pattern

• Colourful vegetables and fruits — providing antioxidants that may help counteract oxidative stress

…can support both follicle health and healthy weight management.

Regular physical activity improves insulin sensitivity, reduces circulating androgens, lowers systemic inflammation, and supports healthy circulation. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, alongside muscle-strengthening activities on two or more days per week.

Stress management is also relevant, as psychological stress is a recognised trigger for telogen effluvium. Techniques such as mindfulness, adequate sleep (7–9 hours per night), and reducing alcohol intake can all contribute to hormonal balance and overall wellbeing.

Finally, avoiding crash diets or very low-calorie diets is important — rapid weight loss is itself a well-documented trigger for telogen effluvium, as the body prioritises essential functions over hair growth during periods of severe caloric restriction. Gradual, sustainable weight loss of approximately 0.5–1 kg per week is recommended by NHS guidance and is far less likely to precipitate hair shedding than extreme restriction. The NHS Better Health weight loss plan provides practical, evidence-based support for safe weight management.

Further reading: NHS Eatwell Guide; UK Chief Medical Officers' Physical Activity Guidelines; NHS Better Health: Weight loss plan; NHS Hair loss.

Frequently Asked Questions